Maravai LifeSciences Holdings, Inc. (MRVI)
After hours:
| Previous close | 7.58 |
| Open | 7.61 |
| Bid | 7.69 x 1000 |
| Ask | 7.74 x 100 |
| Day's range | 7.50 - 7.82 |
| 52-week range | 4.52 - 16.62 |
| Volume | |
| Avg. volume | 2,766,628 |
| Market cap | 1.936B |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
SAN DIEGO, April 18, 2024--TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
- GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2024 financial and operating results after the market closes on Wednesday, May 8, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 a
- GlobeNewswire
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March. On March 19, 2024, at 11:15 a.m. PDT, Trey Martin, Chief Executive Officer will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum being held virtually. A live webcast of t
